Models versus pathogens: how conserved is the FtsZ in bacteria?

Developing new antimicrobial strategies is crucial due to rising resistance. FtsZ has emerged as a potential drug target because of its role in bacterial cell division. Bacillus subtilis and Escherichia coli have been extensively studied for their FtsZ functions. These rod-shaped bacteria represent gram-positive and gram-negative species, respectively. However, less is known about FtsZ in cocci and ovococci. Sequence conservation of FtsZ is widespread, but functional differences exist across species. These differences suggest diverse division mechanisms in bacteria. Prior research has focused on model organisms, leaving gaps in understanding pathogens. This gap motivates a comparative analysis of FtsZ across different bacterial shapes.

This review aims to compare FtsZ features and cell division mechanisms in model organisms and pathogens. The focus is on Bacillus subtilis and Escherichia coli as model rods, and four pathogens with different morphologies. The goal is to highlight functional differences in FtsZ and its interacting proteins. Understanding these differences may reveal new drug targets. The study also examines anti-FtsZ compounds and their mechanisms. The authors aim to emphasize the need for more research on diverse bacterial shapes. They seek to identify current challenges in anti-FtsZ drug development. This work provides a foundation for future studies on FtsZ-targeted therapies.

The authors conducted a comparative review of recent literature on FtsZ and cell division. They selected four pathogens with distinct shapes: Staphylococcus aureus, Streptococcus pneumoniae, Mycobacterium tuberculosis, and Pseudomonas aeruginosa. The study contrasts these with model organisms B. subtilis and E. coli. The review includes analysis of FtsZ functioning and associated proteins. It also examines anti-FtsZ compounds and their target bacteria. The methodology relies on synthesizing findings from multiple studies. The authors highlight unique roles of FtsZ-associated proteins in each species. This approach allows for a comprehensive overview of FtsZ across bacteria.

FtsZ shows sequence and structural conservation across bacteria. However, functional differences exist in how FtsZ interacts with partner proteins. In model organisms, FtsZ forms a division ring at mid-cell. In cocci, FtsZ localization differs, affecting division symmetry. Staphylococcus aureus uses FtsZ in a unique way compared to rods. Streptococcus pneumoniae relies on FtsZ for asymmetric division. Mycobacterium tuberculosis has a distinct FtsZ-dependent division mechanism. Anti-FtsZ compounds show variable efficacy across species. These findings suggest that FtsZ mechanisms are not universally conserved.

The authors propose that FtsZ mechanisms vary significantly across bacterial species. These differences may explain the variable efficacy of anti-FtsZ compounds. The study emphasizes the need for species-specific drug development. They suggest that understanding unique FtsZ functions could lead to better therapies. Current research lacks detailed insights into FtsZ in non-rod-shaped bacteria. The authors highlight gaps in anti-FtsZ drug mechanisms across species. They recommend further studies on FtsZ in cocci and ovococci. This review provides a foundation for future research on FtsZ-targeted therapies.